-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BdEt0XIfyR9FALm4RQDgE0tGo8XpZ9EO8ioaY/BDQzgGup1fW7bLpY92jSCgcxyf kbUC6te44U1cYsa4M8fZ+w== 0001206212-07-000035.txt : 20070208 0001206212-07-000035.hdr.sgml : 20070208 20070208152229 ACCESSION NUMBER: 0001206212-07-000035 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20070208 DATE AS OF CHANGE: 20070208 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: LABOPHARM INC CENTRAL INDEX KEY: 0001284519 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-81788 FILM NUMBER: 07592281 MAIL ADDRESS: STREET 1: 480 ARMAND FRAPPLER BLVD CITY: LAVAL QUEBEC CANADA H7V 4B4 STATE: A8 ZIP: 00000 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC CENTRAL INDEX KEY: 0000903337 IRS NUMBER: 980140536 FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 8717 RUE PERRI STREET 2: MONTREAL QUEBEC CITY: CANADA H2M 2T9 STATE: A8 ZIP: 00000 MAIL ADDRESS: STREET 1: 8717 RUE PERRI STREET 2: MONTREAL QUEBEC CITY: CANADA H2M 2T9 SC 13G 1 m34664lasc13g.htm SCHEDULE 13G sc13g
TABLE OF CONTENTS

ANNEX 1
SIGNATURE

Table of Contents

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Schedule 13G
Under the Securities Exchange Act of 1934
(Initial Statement)
Labopharm inc.
 
(Name of Issuer)
Common Shares
 
(Title of Class of Securities)
504 905 100
 
(CUSIP Number)
Check the following box if a fee is being paid with this statement 9. (a fee is not required only if the filing person: (1) has a previous statement on file reporting beneficial ownership of more than five percent of the class of securities described in Item I; and (2) has filed no amendment subsequent thereto reporting beneficial ownership of five percent or less of such class.) (See Rule 13d-7.)
 
*   The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 
 
Page 1 of 5

 

Table of Contents

                     
CUSIP No.
  
504 905 100 
 13G Page  
2 
   of   
5 

 

           
1   NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) 
   
  Fonds de solidarité des travailleurs du Québec (F.T.Q.) (hereinafter referred to as “Fonds”)
   
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
  (a)   N/A
  (b)   N/A
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Montreal (Quebec) CANADA
       
  5   SOLE VOTING POWER
     
NUMBER OF   5,164,671 Common Shares (this includes 30,000 options which can be exercised by directors to purchase 30,000 Common Shares of the Issuer). By contract, these options belong to Fonds.
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   N/A
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   Fonds has sole dispositive power over 5,164,671 Common Shares.
       
WITH 8   SHARED DISPOSITIVE POWER
     
    Fonds’ representatives who used to sit on the Board of Directors hold 30,000 options which they can exercise to purchase 30,000 Common Shares of the Issuer. By contract, these options belong to Fonds.
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  5,134,671 Common Shares held by Fonds.
30,000 options to purchase 30,000 Common Shares are held by Fonds representatives who used to sit on the board of Directors. By contract, these options belong to Fonds.
     
10   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  N/A
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  9.04% and 9.10% if all the options were exercised.
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  IV

 

Table of Contents

ANNEX 1
ITEM 1
(a)   Name of Issuer: Labopharm inc. (CUSIP 504 905 100)
(b)   Address of Issuer’s Principal Executive offices:
480, boul. Armand-Frappier
Laval (Québec) H7V 4B4
Canada
ITEM 2
(a)   Name of the person filing: Fonds de solidarité des travailleurs du Québec (F.T.Q.) (“Fonds”)
(b)   Address of Principal Business Office:
545, Cremazie blvd. East, suite 200
Montreal (Quebec) CANADA
H2M 2W4
(c)   Citizenship: The Fonds is a stock company and a development capital investment fund established by a special act of the Legislature of the Province of Quebec, Canada. The Fonds is a labour sponsored venture capital fund whose majority of directors is appointed by Fédération des travailleurs du Québec (Quebec Federation of Labour).
(d)   Title of Class of Securities: Common Shares
(e)   CUSIP Number: N/A
ITEM 3
Classification of person filing: N/A
ITEM 4
(a)   Amount beneficially owned : 5,164,671 Common Shares (this includes 30,000 options which can be exercised by directors to purchase 30,000 Common Shares of the Issuer). By contract, these options belong to Fonds.
(b)   Percent of class: 9.04% and 9.10% if all the options were exercised.
Page 3 of 5

 

Table of Contents

(c)   Number of shares as to which such person has:
  i.   Sole power to vote or to direct the vote : 5,164,671 Common Shares (this includes 30,000 options which can be exercised by directors to purchase 30,000 Common Shares of the Issuer). By contract, these options belong to Fonds
  ii.   Shared power to vote or to direct the vote : N/A
  iii.   Sole power to dispose or to direct the disposition of : Fonds has sole dispositive power over 5,164,671 Common Shares
  iv.   Shared power to dispose or to direct the disposition of : Fonds’ representatives who used to sit on the Board of Directors hold 30,000 options which they can exercise to purchase 30,000 Common Shares of the Issuer. By contract, these options belong to Fonds.
ITEM 5
Ownership of 5% or less of a Class: N/A
ITEM 6
Ownership of more than 5% on behalf of another person: N/A
ITEM 7
Identification and classification of the subsidiary acquiring securities: N/A
ITEM 8
Identification and Classification of Members of the Group: N/A
ITEM 9
Notification of dissolution of Group: N/A
ITEM 10
Certification
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
Page 4 of 5

 

Table of Contents

SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
February 1st, 2007.
(S) Chantal Leclerc
Chantal Leclerc
Senior Legal Advisor
Corporate Affairs Department
Page 5 of 5

 

-----END PRIVACY-ENHANCED MESSAGE-----